{"id":"W2950646286","doi":"10.1097/01.hs9.0000564672.91201.a6","title":"S1606 SAFETY AND EFFICACY OF COMBINATION OF SELINEXOR, DARATUMUMAB, AND DEXAMETHASONE (SDD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) PREVIOUSLY EXPOSED TO PROTEASOME INHIBITORS AND IMMUNOMODULATORY DRUGS","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Tolerability; Medicine; Refractory (planetary science); Internal medicine; Oncology; Dexamethasone; Proteasome inhibitor; Phases of clinical research; Carfilzomib; Multiple myeloma; Pharmacology; Lenalidomide; Gastroenterology; Toxicity; Adverse effect; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001451656,0.000134262,0.0003393824,0.0000316919,0.00002801775,0.000005419217,0.00003773536,0.00007700458,0.00002277265],"category_scores_gemma":[0.00007935402,0.0001131436,0.00001869827,0.0001874351,0.0001033467,0.00006820127,0.00004226139,0.0001374897,0.000001295028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002950231,"about_ca_system_score_gemma":0.00003144094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001337889,"about_ca_topic_score_gemma":0.000002245055,"domain_scores_codex":[0.9990764,0.00002761438,0.0003238818,0.0002616184,0.0001752644,0.0001352009],"domain_scores_gemma":[0.999321,0.0001259363,0.0001159403,0.0002123671,0.00009682937,0.0001278687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003713536,0.0009988432,0.831025,0.00156123,0.00006878096,0.000001518556,0.001496672,0.00001950929,0.1417349,0.0001214003,0.00002291136,0.01923573],"study_design_scores_gemma":[0.01346566,0.0006044679,0.8814189,0.0005832748,0.00005022532,0.000004169247,0.0002397889,0.0003222564,0.1029002,0.0000116756,0.0002473076,0.0001520872],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973991,0.0005239625,0.00002269456,0.000100826,0.00001017728,0.001672438,0.00001052268,0.00001334559,0.0002469494],"genre_scores_gemma":[0.9985924,0.00002706888,0.001178831,0.00002827198,0.00001058598,0.00002883619,0.00002411088,0.00001619886,0.00009374294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05039388,"threshold_uncertainty_score":0.4613864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006718724720766075,"score_gpt":0.2381503459862727,"score_spread":0.2314316212655067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}